{
  "weekly_top_story": {
    "headline": "FDA Clears Cryoablation System for Early-Stage Breast Cancer in Older Adults",
    "summary": "The FDA granted marketing authorization for the ProSense Cryoablation System, a minimally invasive device that freezes small, early-stage breast cancers in women 70+ not suitable for surgery, offering a new treatment option for this patient group.",
    "source": "MedPage Today",
    "importance": 4,
    "impact_to_me": 4,
    "category": "Tech",
    "url": "https://kffhealthnews.org/morning-briefing/tuesday-october-7-2025/"
  },
  "stories": [
    {
      "headline": "Senate Special Committee on Aging to Hold Hearing on 'Bad Medicine: Closing Loopholes that Kill American Patients'",
      "summary": "The Senate Special Committee on Aging will hold a hearing on October 8, 2025, to discuss regulatory loopholes contributing to preventable patient deaths, a critical issue for drug safety and patient care.",
      "source": "Holland & Knight",
      "importance": 4,
      "impact_to_me": 3,
      "category": "Policy",
      "url": "https://www.hklaw.com/en/insights/publications/2025/10/holland-knight-health-dose-october-7-2025"
    },
    {
      "headline": "India Probes Contaminated Cough Syrup Linked to At Least 14 Child Deaths",
      "summary": "Indian authorities launched a criminal investigation after at least 14 children died from consuming contaminated cough syrup in Madhya Pradesh, highlighting ongoing concerns about global pharmaceutical quality control.",
      "source": "KFF Health News",
      "importance": 4,
      "impact_to_me": 3,
      "category": "Pharma",
      "url": "https://kffhealthnews.org/morning-briefing/tuesday-october-7-2025/"
    },
    {
      "headline": "AstraZeneca\u2019s Datroway Shows Improved Survival in Triple-Negative Breast Cancer",
      "summary": "AstraZeneca announced that Datroway, a drug co-developed with Daiichi Sankyo, significantly improved survival and delayed disease progression in patients with advanced, inoperable triple-negative breast cancer who are ineligible for immunotherapy.",
      "source": "KFF Health News",
      "importance": 4,
      "impact_to_me": 4,
      "category": "Pharma",
      "url": "https://kffhealthnews.org/morning-briefing/tuesday-october-7-2025/"
    }
  ]
}